cardiovascularhealth hashtag performance

A Cup A Day - Clear Clogged Arteries And Heart #HeartHealth #ClearArteries #HealthyHeart #WellnessTips #NaturalRemedies #CardiovascularHealth #HealthyLifestyle #BetterLiving #nutritiontips #PreventHeart

Best way to optimize your health in your 50s #cardiovascularhealth #preventivemedicine #5thingsiwouldneverdo #atherosclerosis

If You're Over 70 with High Blood Pressure, Watch This #bloodpressure #hypertension #hearthealth #seniorhealth #healthtips #healthyaging #cardiovascularhealth #naturalremedies #wellness #longevity

What’s your biggest threat? Heart or boobs gonna end you? Do we focus all wrong and blame HRT? * This is general educational information not specific medical advice meant for any individual #heartdisease #cardiovascularhealth #hearthealth #breasthealth #breastcancer #hrt #hormonereplacementtherapy #perimenopause #menopause #obgyn #thevagdoc

Can I Get Off Blood Pressure Medication? #bloodpressurecontrol #hearthealthtips #naturalloweringbp #healthylifestyle #lowersbpnaturally #wellnesstips #cardiovascularhealth #healthyhabits #bpmanagement #holistichealth

Can you lower BLOOD PRESSURE in MINUTES? #BloodPressure #HeartHealth #LowerBP #HealthyLifestyle #WellnessTips #QuickRelief #NaturalRemedies #HealthHacks #HealthyLiving #CardiovascularHealth

How to Improve Blood Flow Blood Pressure, Nitric Oxide, and other Stuff #BloodFlow #HeartHealth #NitricOxide #BloodPressure #HealthyLifestyle #WellnessTips #CirculationHealth #HealthHacks #NaturalRemedies #CardiovascularHealth

1 Vital Mineral Your Heart Needs Now #hearthealth #wellness #bloodpressure #minerals #healthyliving #SelfCare #nutritiontips #cardiovascularhealth #healthtips #naturalremedies

Arthrosclerosis for dummies. Doc gives a visual explanation of whats happening inside your body and what poses the most risk when it comes to heart attack and stroke #cardiovascularhealth #preventivemedicine #5thingsiwouldneverdo #atherosclerosis

High Cholesterol Symptoms, Risk Factors and Treatment #cholesterolawareness #hearthealth #loweryourcholesterol #healthytips #cholesterolmanagement #cardiovascularhealth #wellnessjourney #nutritiontips #healthylifestyle #preventioniskey

“The new move comes as Eli Lilly has also taken action against compounders making copies of tirzepatide, its GLP-1 and GIP agonist sold as Mounjaro for diabetes and Zepbound for obesity in the US.” “Lilly has filed to lend its support to the FDA in a lawsuit filed against the agency by the OFA and FarmaKeio Custom Compounding, which are challenging a decision to remove tirzepatide from the shortages list and bring an end to compounding of the drug.” “As it stands, pharmacies and outsourcing facilities are required to wind down production of tirzepatide by 18th February and 19th March, respectively.” “Lilly has also argued that the presence of compounded products in the supply chain makes it harder for patients to ensure they buy a legally produced version, as the market has been flooded with illicit copies.” "Sometimes these knockoff medicines – which come from places like China and India – are sold by entities that cannot even legally sell them in their own countries," said Patrik Jonsson, president of Lily USA. #zepboundtips #SelfWorthMatters #SelfCareTips #GLP1Journey #SelfCareJourney #ResearchBasedWellness #ObesityIsADisease #mentalhealthmatters #SelfWorthMatters #WomenSupportingWomen #cardiovascularhealth #glp1community #zepboundjourney #fyyyyyyyyyyyyyyyy

herbal tea blend today is called heart tonic and it is all about stress relief, reducing inflammation and strengthening the heart muscle and lowering blood pressure also as well to help naturally regulate blood pressure ##HeartHealth##HerbalTea##NaturalRemedies##Linden#HawthornBerry##Hibiscus##Tulsi##CardiovascularHealth##LowerBloodPressure##StressRelief##HealthyHeart##HolisticHealth##HerbalMedicine##WellnessJourney##Adaptogens##NaturalHealing##TeaTime

Tune into Modern Thyroid & Wellness on your favorite podcast platform to hear the full epsiode with Dr. Amy Killen! Recent studies reveal that starting estrogen replacement therapy early can significantly reduce the risk of cardiovascular disease by up to 50%. In this video, we explore the powerful impact of estrogen on heart health and why it deserves more attention. #Estrogen #CardiovascularHealth #HRT #Thyroid #HeartDisease #Menopause #Hormones

“On the contrary, emerging evidence indicates that GLP-1RAs might reduce specific symptoms, such as binge eating, in individuals with higher weight who do not have diabetes. Nevertheless, further research is needed to clarify their potential therapeutic role and risks in BED. To date, GLP-1RAs can be considered in people with BED as part of a healthy weight-loss strategy in conjunction with lifestyle changes, but only after binge-eating episodes have significantly decreased and regular eating patterns are well established.”#mentalhealthmatters #SelfCareJourney #GLP1Journey #SelfCareTips #fy #SelfWorthMatters #zepboundtips #WomenSupportingWomen #fypシ #ObesityIsADisease #ResearchBasedWellness #cardiovascularhealth #glp1community #fyp

“The seeming endorsement of medications such as Ozempic, Wegovy, Mounjaro and Zepbound from two people who have Trump's ear is likely to be a relief for the pharmaceutical industry following Kennedy's sharp questioning of America's reliance on weight-loss medications. Previously, Kennedy has said that if America paid more for quality food, it would solve the obesity crisis "overnight" -- a statement obesity experts criticized as overly simplistic.” #glp1community #WomenSupportingWomen #cardiovascularhealth #fypシ #GLP1Journey #SelfCareJourney #SelfCareTips #fyyyyyyyyyyyyyyyy #cardiovascularhealth #zepboundjourney #zepboundtips #ResearchBasedWellness #SelfWorthMatters #ObesityIsADisease #fy

“List prices for a month's supply of GLP-1s range from about $936 to $1,349 before insurance, which often doesn't pay enough for people to afford the drugs, according to Kaiser Family Foundation research.” “Widespread shortages have prevented some patients from getting prescriptions filled, though the FDA has said the shortages are improving. Meanwhile, pharmacies are introducing compounded alternatives that critics say allow them to skirt regulatory review.” #SelfWorthMatters #SelfCareJourney #ResearchBasedWellness #zepboundtips #SelfCareTips #WomenSupportingWomen #GLP1Journey #glp1community #ObesityIsADisease #cardiovascularhealth #mentalhealthmatters #zepboundjourney #fy

“Dr. Cynthia Cox, vice president at KFF (formerly Kaiser Family Foundation), a nonprofit that offers information, analysis and research on health policy, acknowledged the potential health benefits but noted the financial challenge.” "These drugs cost around $500 to $1,000 per month. So, even if they prevent diabetes or heart disease down the road, that potential savings isn't enough to offset the high monthly cost of the drug," she told Newsweek. “According to a KFF analysis, the list price of Ozempic in the United States is $936 per month, more than five times the cost in Japan, where it sells for $169—the second-highest price among the countries studied. Similarly, Wegovy, another medication with the same active ingredient as Ozempic, is roughly four times as expensive in the U.S. ($1,349) compared to Germany ($328).” #SelfCareJourney #SelfCareTips #SelfWorthMatters #cardiovascularhealth #fyyyyyyyyyyyyyyyy #ResearchBasedWellness #glp1community #WomenSupportingWomen #zepboundjourney #zepboundtips #ObesityIsADisease #GLP1Journey #fy #fyp

“Background: Endogenous glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) regulate islet cell function. GLP-1 receptor agonists (GLP-1RAs) have been associated with an elevated risk of acute pancreatitis. Data on the pancreatic safety of tirzepatide (a dual GLP-1 and GIP agonist) and its effects on islet cell function in randomized controlled trials (RCTs) are scarce. Moreover, no meta-analysis has comprehensively examined such effects of tirzepatide.” Methods: “Electronic databases were searched for RCTs with tirzepatide as the intervention and a placebo or active comparator as the control. The primary outcome was adjudication-confirmed pancreatitis; secondary outcomes were the percent changes from baseline in serum pancreatic amylase, lipase, insulin, C-peptide, glucagon, and homeostasis model assessment of insulin resistance (HOMA2-IR).” Results: “Seventeen RCTs with 18 published reports involving 14,645 subjects were analyzed. Over a follow-up duration of 12-72 weeks, tirzepatide had identical risks of pancreatitis to placebo (tirzepatide 5 mg: RR 2.04, 95% CI [0.27-15.69], p = 0.49; 10 mg: RR 0.63, 95% CI [0.08-5.12], p = 0.67; and 15 mg: RR 1.26, 95% CI [0.36-4.98], p = 0.72). Tirzepatide was also associated with comparable risks of pancreatitis to insulin and GLP-1RAs. However, tirzepatide (at all doses) caused greater increases in pancreatic amylase and lipase than placebo and insulin. Individuals on tirzepatide 15 mg and GLP-1RAs had similar risks of having increased lipase levels. The percent reductions in fasting insulin were greater with tirzepatide 10 and 15 mg than with placebo. All doses of tirzepatide caused greater percent reductions in fasting insulin, C-peptide, and glucagon than GLP-1RAs. Compared to placebo and GLP-1RAs, the percent reductions in HOMA2-IR were greater with all doses of tirzepatide.” #glp1community #ObesityIsADisease #zepboundtips #WomenSupportingWomen #GLP1Journey #ResearchBasedWellness #cardiovascularhealth #SelfWorthMatters #zepboundjourney #SelfCareJourney #SelfCareTips #mentalhealthmatters #fy

💥 What does grip strength say about your future health? A lot, actually. Research shows that #gripstrength is a strong predictor of: 🫀 Heart health: A weaker grip is linked to higher #cardiovascularhealth risk. 🦴 Bone density: Exercises like the Farmer’s Carry strengthen bones, #osteoporosis risk. 🧠 Cognitive function: Grip strength is associated with better #brainhealth as we age. 🏋️‍♀️ Longevity: It’s even considered a marker of biological #aging and overall health. The #farmercarry isn’t just about carrying weight—it’s about #buildingstrength for the years ahead. 📋 How to do it: 1️⃣ Select appropriate weights: The goal is to carry a total of 75% of your body weight for 60 seconds. For example, if you weigh 140 pounds, carry 52.5 pounds in each hand. 2️⃣ Maintain proper #posture: Stand tall with shoulders back, chest open, and core engaged. 3️⃣ Walk for 60 seconds: If you can’t make it to 60 seconds, drop the weight and train with a lighter load until you get stronger or improve. Gradually increase the weight over time to reach the goal of 75% of your body weight. 4️⃣ Rest and repeat: Aim for 2-3 sets per session. 💡 This simple but powerful exercise supports your strength, mobility, and independence as you age. #MidlifeWellness #StrongNotStuck #FutureProofFitness #GripStrength #FunctionalFitness #HealthyAging #StrengthTraining #LongevityMatters #BoneHealth

“A disproportionality analysis detects significant associations between drugs and adverse events. However, the FAERS can also provide information on inverse associations that may serve to identify potential drug repurposing avenues.” “Shirani and the team analyzed anti-diabetic and non-diabetic drugs with weight loss-inducing effects. Anti-diabetic medications included the glucagon-like peptide-1 (GLP-1) receptor agonists semaglutide (marketed as Ozempic and Rybelsus for diabetes and Wegovy for weight loss), tirzepatide (sold as Mounjaro for diabetes and Zepbound for weight loss), Trulicity (dulaglutide), and liraglutide (available as Saxenda and Victoza); the sodium-glucose cotransporter-2 (SGLT-2) inhibitors Jardiance (empagliflozin), Invokana (canagliflozin), and Farxiga (dapagliflozin); and the biguanide metformin.” #SelfCareTips #mentalhealthmatters #fy #WomenSupportingWomen #glp1community #SelfWorthMatters #fyyyyyyyyyyyyyyyy #ObesityIsADisease #zepboundjourney #GLP1Journey #SelfCareJourney #ResearchBasedWellness #cardiovascularhealth #zepboundtips #fyp

“From the pioneering moment in 1987 when the insulinotropic effect of glucagon-like peptide 1 (GLP-1) was first demonstrated in humans, to today's pharmaceutical gold rush for GLP-1-based treatments of obesity, the journey of GLP-1 pharmacology has been nothing short of extraordinary. The sequential conceptual developments of long-acting GLP-1 receptor (GLP-1R) mono-agonists, GLP-1R/glucose-dependent insulinotropic polypeptide receptor (GIPR) dual-agonists, and GLP-1R/GIPR/glucagon receptor (GcgR) triple agonists, have led to profound body weight-lowering capacities, with benefits that extend past obesity and towards obesity-associated diseases. The GLP-1R/GIPR dual-agonist tirzepatide has demonstrated a remarkable 23% body weight reduction in individuals with obesity over 72 weeks, eclipsing the average result achieved by certain types of bariatric surgery. Meanwhile, the GLP-1R/GIPR/GcgR triple-agonist retatrutide achieves similar body weight loss (∼25%) in just two-thirds of the time, potentially surpassing the efficacy of Roux-en-Y gastric bypass. These remarkable achievements rightfully raise the question whether and why there is still need for novel anti-obesity medications (AOMs) in the future.” #ObesityIsADisease #ResearchBasedWellness #fypシ #SelfCareTips #SelfWorthMatters #glp1community #cardiovascularhealth #fy #mentalhealthmatters #SelfCareJourney #GLP1Journey #zepboundtips #zepboundjourney #fyp